"The rate of implantation reached four Aeson hearts per month in the second quarter of this year, a doubling compared to the first quarter's rate of 2 hearts per month," the medical technology group said in a statement.
Carmat also said it expected sales to continue to grow in the second half of the year, to reach an estimated €14 million in annual sales, as previously announced.
(Written by Augustin Turpin, edited by Kate Entringer)